相关实验视频

Updated: Jun 22, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Amicis Omnia Sunt Communia:NF-κB抑制作为克服骨肉瘤异质性的替代方案

Mariana Medeiros¹, Sophia Guenka², David Bastos²

¹Cell Biology Department, Ribeirão Preto Medical School, University of São Paulo, Avenida Bandeirantes, 3900-Vila Monte Alegre, Ribeirão Preto 14040-900, São Paulo, Brazil.

Pharmaceuticals (Basel, Switzerland)

|June 27, 2024

概括

核因子kappa B (NF-κB) 在骨髓瘤中经常失调,影响瘤异质性. 针对NF-κB提供了一个有前途的治疗策略,通过简化骨髓瘤治疗中的复杂分子网络.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症信号通路癌症信号通路

背景情况:

骨髓瘤 (OS) 治疗因瘤异质而复杂.
"奥米克"时代已经确定了许多生物标志物和信号通路 (例如PI3K/AKT/mTOR,WNT/β-catenin,NOTCH,SHH/GLI) 涉及到OS.
核因子kappa B (NF-κB) 是癌症中常见的失调途径,包括OS.

研究的目的:

为了突出显示骨髓瘤中NF-κB的失调.
探索NF-κB与OS中的其他癌症相关信号通路的整合.
要总结针对NF-κB活性的化合物.

主要方法:

使用in silico策略来分析NF-κB相互作用.
文献审查以确定干扰NF-κB的化合物.
分析NF-κB在调节其他信号通路中的作用.

主要成果:

通过功能相互作用和转录调节,NF-κB与OS中的其他失调途径密切协调.
NF-κB在多种癌症特征中发挥作用.
对于各种与OS相关的途径,NF-κB作为一个共同的下游效应因子.

结论:

向NF-κB是骨髓瘤的重要治疗机会,因为它发挥着核心作用.
抑制NF-κB可以简化理解OS异质性背后的复杂分子网络.
尽管目前的抑制剂存在局限性,但NF-κB的多功能性使其成为一个令人信服的治疗标.

关键词:

这就是NF-κBB.一个共同的效应器.不同质性的异质性骨质骨髓瘤 (osteossarcoma) 是一个信号通道是指信号通道.

更多相关视频

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...